Fu, X., Hu, J., Han, H., Hua, Y., Zhou, L., Shuai, W., . . . Liu, R. (2015). High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy. Oncotarget.
Chicago-tyylinen lähdeviittausFu, Xiang, et al. "High Expression of XPA Confers Poor Prognosis for Nasopharyngeal Carcinoma Patients Treated With Platinum-based Chemoradiotherapy." Oncotarget 2015.
MLA-viiteFu, Xiang, et al. "High Expression of XPA Confers Poor Prognosis for Nasopharyngeal Carcinoma Patients Treated With Platinum-based Chemoradiotherapy." Oncotarget 2015.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.